2.1 |
Quantify and track the incidence, prevalence, demographics, and risk factors associated with CLTI in different global regions. |
2.2 |
Describe the contemporary natural history of CLTI (including risk to the limb, cardiovascular events, and all-cause mortality in that population) in different global regions. |
2.3 |
Describe the contemporary management strategies used in the treatment of CLTI around the world and the associated outcomes. |
2.4 |
Describe and monitor the incidence and prevalence of nontraumatic lower limb amputation around the globe (eg, the Global Amputation Study, https://GAS.vascunet.org). |
2.5 |
Establish a reliable system to monitor the number of major amputations in as many countries and regions as possible. Time trends and differences around the globe could then be studied. |